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Abstract The role of somatostatin (SS-14) in the regulation of rat liver regeneration was examined by using 
thymidine incorporation into hepatocyte DNA labeled with tritiated thymidine, a nuclear-labeling index, and the binding 
of 1251-tyr11-SS-1 4 to hepatocytes isolated at various times after partial hepatectomy. The data demonstrated no 
suppressive effect of SS-14 on insulin and glucagon-stimulated thymidine incorporation into hepatocyte DNA as early ds 
2 h after partial hepatectomy. These data were substantiated by a nuclear labeling index studies. At 2 h, 1251-tyr11-SS-l 4 
binding to its specific sites on isolated hepatocytes was undetectable. There was a time-dependent increase in binding 
of 12sl-tyr11-SS-l 4 to hepatocytes obtained at various times after partial hepatectomy. There was a significant decrease in 
the number of binding sites after partial hepatectomy as determined by Scatchard analysis. The data were supported by 
autoradiography analysis of affinity labeled 12s1-tyr11-SS-l +binding protein complex followed by SDS-PAGE. SS-14 also 
inhibited intracellular CAMP in hepatocytes obtained at 18 h after hepatectomy. The data are consistent with the 
hypothesis that SS-14 participates via i t s  own receptor in the regulation of the liver regeneration. 
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Somatostatin (SS-14), a 14 amino acid pep- 
tide, was first isolated from the hypothalamus 
as an inhibitor of growth hormone secretion 
[Brazeau et al., 19731 and has been shown to 
have paracrine, autocrine, and endocrine action 
on brain and gastrointestinal functions [Brazeau 
et al., 1973; Larsson et al., 19791. Somatostatin 
and its analogues are potent inhibitors of sev- 
eral tumors and pancreas and cultured hepato- 
cyte proliferation [Harris, 1990; Morriset, 1984; 
Kokudo et al., 19911. Nanomolar concentrations 
of SS-14 inhibit DNA synthesis stimulated by 
insulin and other growth factors in normal cul- 
tured male rat hepatocytes, but selectively in- 
hibit it in human hepatoma cells [Chou et al., 
19871. Further, the inhibitory effect of insulin 
and IBMX-stimulated hepatocytes proliferation 
appears to  be mediated by the adenylate cyclase 
system [Raper et al., 1991bl. 
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In addition to the potent inhibitory effect of 
SS-14 on hepatocyte proliferation in culture, the 
liver has been shown to be a major site of SS-14 
metabolism [Conlon et al., 1981; Ruggere and 
Patel, 1985; Raper et al., 1991al. After an intra- 
hepatic injection 1251-tyr11-SS-14, we [Raper et 
al., 1991aI found the highest amount of injected 
1251-tyrll-SS-14 in the liver and bile. The hepatic 
uptake of 1251-tyr-SS-14 decreases significantly 
when synthetic SS-14 is injected, suggesting 
specific receptor mediated action. Specific and 
saturable binding sites of molecular weight of 
70,000 daltons have been demonstrated on rat 
liver plasma membranes [Raper et al., 19921. 
To test the hypothesis that SS-14 can regulate 
the early phase of hepatocyte proliferation, we 
studied its effect at different time intervals on 
the EGF stimulated tritiated thymidine incorpo- 
ration into isolated rat hepatocyte DNA. Expo- 
sure of hepatocytes to SS-14 between 0 and 24 h 
significantly inhibited EGF stimulated hepato- 
cytes proliferation but had no effect when SS-14 
was added between 48-72 h [Kokudo et al., 
19921. 
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In the present study, we examined the effects 
of SS-14 on insulin stimulated isolated normal 
and regenerating liver hepatocytes proliferation 
and CAMP levels. We also identified and charac- 
terized SS-14 binding sites on these hepato- 
cytes. We conclude that SS-14 may function as a 
regulator of a negative control for the hepato- 
cytes proliferation via its receptor. 
MATERIALS AND METHODS 
Chemicals 
Protease inhibitors and agarose were bought 
from Sigma Chemical Co. (St. Louis, MO). Pep- 
tides were obtained from Peninsula Laboratory 
(Belmont, CAI. Radioactive chemicals were ob- 
tained from Amersham (Arlington, IL). Re- 
agents for gel electrophoresis and protein estima- 
tions were obtained from Bio-Rad Laboratories 
(Richmond, VA). Disuccimidyl suberate (DSS) 
was obtained from Boeringer-Mannheim (India- 
napolis, IN). Reagents for autoradiography were 
obtained from Eastman Kodak Co. (Rochester, 
NY) .
Partial Hepatedomy and Hepatocyte Isolation 
Partial hepatectomy (70% HTX) was per- 
formed on an anesthetized Sprague-Dawley male 
rat (250-275 g) after midline laparotomy by 
aseptic extirpation of the median and left lateral 
lobes [Hashimoto et al., 19931. The mortality 
rate was less than 2%. Hepatocytes from sham 
operated rat livers or from regenerating livers 
were isolated using a two-step collagenase perfu- 
sion technique as described previously [Hashi- 
mot0 et al., 19931. Since we have compared 
hepatocytes obtained from regenerating livers, 
sham operated rats are referred to  as controls in 
the text. Hepatocyte viability was tested by 
trypan blue exclusion ( > 90%). The hepatocytes 
were plated at a cell density of lo5 per 16-mm 
tissue culture dish coated with 250 p1 (1:3 v/v) 
of Matrigelm (laminin, heparin sulfate, type IV 
collagen) and were examined under the micro- 
scope daily. Hepatocytes were also obtained from 
sham operated rats, and are referred to as con- 
trol rats. 
lmmunoblot 
In order to ascertain that there was no cell 
toxicity due to addition of reagents, we have 
monitored the secretion of albumin in the cul- 
ture media and the data are reported in our 
previous publications [Hashimoto et al., 1993; 
Raper et al., 1991bl. Secreted albumin was dem- 
onstrated by immunoblots using antirat albu- 
min antibodies as described previously. Morphol- 
ogy of the cells did not change for the duration of 
the experiment. 35S-Cysteine incorporation into 
cells was previously analyzed by immunoprecipi- 
tation of albumin in media. This lead us to 
conclude that the cultures contained viable hepa- 
tocytes for use in our studies. 
Estimation of DNA Synthesis 
DNA synthesis was estimated by the rate of 
3H-thymidine incorporation into DNA and by 
autoradiography measurement of the number of 
labeled nuclei [Hashimoto et al., 19931. Briefly, 
hepatocytes were plated for 24 h in minimum 
essential medium (serum free). After 24 h of 
attachment, fresh media containing the re- 
agents was added. 3H-thymidine was added 6 h 
after reagents were added. Cells were harvested 
18 h after addition of 3H-thymidine. Half of the 
harvested cells were processed for 3H-thymidine 
incorporation and the other half of the cells 
were used to determine DNA content. 3H-Thymi- 
dine incorporation was monitored by filtering 
cells on to  glass microfiber Whatman filters 
(Whatman International, Maidstone, U.K.), 
rinsed with 1.0 ml of 15% ice-cold trichloroacetic 
acid two times and then 1.0 ml of 70% ethanol 
once. Filters were dried and then placed in 10 ml 
of scintillation cocktail (Ecolite, ICN Biochemi- 
cals Inc., Irvine, CA) and were counted in a 
scintillation counter (Beckman LS 6000 LL, 
Beckman Instruments, Fullerton, CAI. A modi- 
fied diphenylamine reaction for desoxypentose 
was performed to measure DNA content. 3H- 
thymidine incorporation was expressed as cpmi 
pgDNA. Nuclei labeled with 3H-thymidine was 
also measured. 
The labeling index, i.e., the percentage of nu- 
clei labeled with 3H-thymidine, was measured as 
follows. After 18 h exposure to 3H-thymidine (2 
pCi/dish), hepatocytes were washed twice with 
ice-cold phosphate-buffered saline and fixed in 
4% paraformaldehyde for 10 min, coated with 
Kodak NTB-3 emulsion, and exposed for 10 days 
before development. The percentage of morpho- 
logically defined hepatocytes with labeled nuclei 
was determined by phase contrast microscopy. 
Binding Assay 
Labeling of the somatostatin ligand (tyr"-SS- 
14) and binding studies were performed as de- 
scribed previously [Raper et al., 19921. Briefly, 
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binding of 1251-tyr11-SS-14 (50 pM) to hepato- 
cytes (2 x 105/ml) was carried out in 0.5 ml of 
binding buffer (1 mM NaHCO,, 0.5 mM CaC12, 2 
pM leupeptin, 2 ~ L M  pepstatin, 1 mM PMSF, 
and 0.1 mg/ml bacitracin) at pH 7.5, for 30 rnin 
at 25°C. Hepatocytes 1251-tyr11-SS-14 was sepa- 
rated by centrifugation and washed with 1.0 ml 
of icecold binding buffer. The pellet's radioactiv- 
ity was monitored by a gamma-counter. 1251-tyr11- 
SS-14 binding to hepatocytes in the presence of 
10 pM SS-14 was considered to be nonspecific 
binding. Specific binding was obtained by sub- 
tracting nonspecific counts from counts ob- 
tained in absence of SS-14, followed by division 
with total counts minus nonspecific counts. Non- 
specific binding was less than 5%. 
Affinity Cross-Linking 
One million hepatocytes obtained from con- 
trol rats and at various intervals after partial 
hepatectomy were incubated in 0.5 ml of bind- 
ing buffer in the presence 1251-tyr11-SS-14 (200 
pmol/L) for 30 rnin at 25°C. The mixture was 
centrifuged at 10,OOOg for 15 min at 4°C. The 
pellet was washed with 1.0 ml of icecold binding 
buffer and then centrifuged at  10,OOOg for 10 
min at 4°C. The homobifunctional cross-linking 
agent DSS was prepared in DMSO (1:lOO) at 
final concentration of 1 mM. The reaction be- 
tween pellet and DSS was allowed to proceed for 
20 rnin at 4°C and then quenched with 1 ml of 1 
M ammonium acetate for 5 min at 25°C. Pellets 
were washed with ice-cold binding buffer and 
the subjected to SDS-PAGE. 
SDS-PACE 
SDS-PAGE analysis is described in detail in 
our previous publication [Raper et al., 19921. 
Briefly, affinity cross-linked membranes were 
solubilized in the sample buffer (0.0625 M Tris- 
HC1, pH 6.81, 5% P-mercaptoethanol (v:v), 2.3% 
SDS (wt:v), 10% glycerol (v:v), and 5% bromophe- 
no1 blue (wt:v) by heating at 100°C for 3 min. 
Samples were then subjected to electrophoresis 
in 7.5% acrylamide and 1% SDS. Gels were fixed, 
silver stained for the identification of the molecu- 
lar markers, and dried. Autoradiography was 
performed on dried gels by exposing them to 
Kodak X-Omat AR film with an enhancing screen 
at - 70°C. Cross-linking efficiency was 1-2% as 
determined by counting the radioactivity of the 
cut dried laneblocks (0.5 cm). 
Statistical Analysis 
All values shown represent the mean +- SEM. 
Wilcoxon signed rank or Student's t-test, ,as 
appropriate, to compare the various groups. So- 
matostatin effects on insulin stimulated 311- 
thymidine incorporation, CAMP synthesis, arid 
nuclear labeling index were also performed by 
analysis of variance (ANOVA). The level of sig- 
nificance was established at P < 0.05. 
RESULTS 
The cultures of isolated hepatocytes from re-  
generating liver and intact liver had the known 
characteristics. Hepatocytes, when cultured on 
Matrigelm, attached rapidly and exhibited mini- 
mal spreading, which was different from the 
flattened appearance of hepatocytes cultured on 
plastic. The cells were polygonal and nucleated 
The control experiments showed no fibroblast,ic 
growth during experimental time. 
Preliminary experiments showed that 20 nM 
insulin significantly stimulated tritiated thymi- 
dine incorporation into control rat hepatocytes 
DNA using various concentrations of insulin. 
Further, 10 nM of SS-14 significantly inhibited 
insulin stimulated tritiated thymidine incorpora- 
tion into control rat hepatocytes DNA [Raper et 
al., 1991bI. Hence, concentrations of 20 nM of' 
insulin and 10 nM of somatostatin were used in 
the experiments in the present study. 
As shown in Figure 1, SS-14 significantly in- 
hibited insulin-stimulated tritiated thymidine 
incorporation in culture obtained from control 
rat livers. In contrast, there was no significant 
inhibition of insulin-stimulated tritiated thymi- 
dine incorporation in hepatocytes obtained from 
the rats liver 2, 6, 18, and 24 h after partial 
hepatectomy . The percentage of nuclei labeled 
with tritiated thymidine, or nuclear labeling in- 
dex, is shown in Table I. SS-14 significantly 
inhibited the insulin stimulated labeling index 
in control operated rat hepatocytes but did not 
inhibit it in hepatocytes obtained at 18 h after 
partial hepatectomy . 
Since glucagon is a known mitogen for hepato- 
cyte proliferation, we determined the effects of 
SS-14 on glucagon stimulated tritiated thymi- 
dine incorporation in hepatocytes in culture ob- 
tained from control and 18 h regenerating rat 
livers. As shown in Figure 2, SS-14 significantly 
inhibited tritiated thymidine incorporation in 
hepatocytes obtained from control rats, but there 
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Sham 2 6 
Hours 
Fig. 1. Effect of SS-14 on insulin-stimulated tritiated thymi- 
dine incorporation into hepatocyte DNA in control and hepatec- 
tornized rats. On  ordinate, tritiated thymidine incorporation in 
TABLE I. Effect of SS-14 in Insulin 
Stimulated Nuclear Labeling Index in 
Hepatocytes Obtained at 18 h After 
Partial Hepatectomy+ 
% Nuclear labeling 
(mean ? SEM) 
Control HTX 
MEM 24.6 ? 5.3* 18.9 ? 2.7*** 
Insulin 20 nM 38.5 ? 7.7*3** 42.6 ? 7.1*** 
Insulin 20 nM + 
SS-14 10 nM 23.1 ? 4.3** 34.7 * 7.2 
'Statistical analysis was performed by ANOVA. 
*,**,***I' < 0.05, when compared w i t h  each other. 
was no inhibition of in hepatocytes obtained 
from the 18 h regenerating livers. 
We have reported that insulin stimulated 
CAMP accumulation in hepatocytes obtained 
from sham operated rats was inhibited by SS-14 
[Raper et al., 1991bl. However, insulin stimu- 
lated CAMP accumulation in hepatocytes ob- 
tained 18 h after partially hepatectomized rats 
was significantly inhibited by SS-14 (Table 11). 
Further, intracellular CAMP levels were signifi- 
cantly higher in hepatocytes obtained from re- 
generating livers than control livers. 
To determine whether SS-14 acts via its own 
receptor on hepatocytes, we examined the bind- 
ing of 1251-tyr11-SS-14 to hepatocytes at various 
times. As shown Figure 3, the binding of 1251- 
tyrll-SS-14 to hepatocytes in control rats was 
significantly higher than hepatocytes obtained 
after partial hepatectomy. There was a time 
dependent increase in binding to hepatocytes 
that were obtained from hepatectomized rats. 
18 24 
control and at 2, 6, 18, 24  h after partial hepatectomy is 
expressed as a percentage of i t s  own matched control. The 
vertical bar indicates mean t- SEM. *P  < 0.05 (N 2 6). 
6ooo 1 
I **, # 
1 T 
# 
MEM -1 0 - 8  
SS-14 log (M) 
Effect of SS-14 on glucagon-stimulated tritiated thymi- 
dine incorporation into hepatoiyte DNA in control (closed 
circle) and 1 8  h regenerating liver (open circle). Tritiated thymi- 
dine incorporation in control and at 18 h after partial hepatec- 
tomy is indicated on ordinate. The vertical bar indicates mean r 
SEM. *, **, # = P < 0.05. MEM = minimum essential media 
iN 2 3) .  
1251-tyr11-SS-14 binding to  hepatocytes was unde- 
tectable at 2 h after hepatectomy, and was signifi- 
cantly less at  6 ,  18, and 24 h after hepatectomy 
than that of control rats. 
In order to determine whether the decreased 
binding of 1251-tyr11-SS-14 to hepatocytes ob- 
tained from regenerating livers in comparison to 
control livers is due to change in the affinity of 
the receptors to bind 1251-tyr11-SS-14 or in its 
number, we studied the competition binding 
curve profiles using synthetic SS-14. As shown 
in Figure 4, increasing concentrations of syn- 
thetic SS-14 to the hepatocytes obtained 18 h 
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TABLE 11. Effect of SS-14 in Insulin 
Stimulated Intercellular CAMP in Hepatocytes 
Obtained at 18 h After Partial Hepatectomy 
CAMP (pmol) 
(mean -+ SEMI 
Control HTX 
MEM 0.180 f 02*,# 0.42 f 0.11#,** 
Insulin 20 nM 0.45 -+ 0.08*3@' 1.62 ? 0.37**9*** 
Insulin 20 nM + 
SS-14 10 nM 0.23 -+ 0.32" 0.93 * 0.46*** 
*.@I,#.**.*** = p < 0.05, when compared w i th  each other. 
* 
T 
Sham 2 6 18 24 
Hours 
*=p<O.OS when compared with Sham 
Fig. 3. Binding of 1251-tyr'1-SS-14 to hepatocytes during liver 
regeneration. Specific binding to hepatocytes after 2, 6, 18, or 
24 h after partial hepatectomy is indicated on ordinate, and is 
expressed as a percent of the control rats. The vertical bar 
indicates mean ? SEM. * P  < 0.05 when compared with control 
group (N t 3 ) .  Specific binding was calculated by subtracting 
total binding at each point minus the nonspecific binding (see 
Materials and Methods). 
after partial hepatectomy and control livers re- 
sulted in a characteristic competition binding 
profile. Further 1251-tyr11-SS-14 binding to hepa- 
tocytes obtained from control livers and 18 h 
regenerating livers showed two binding sites in 
each case. There was no statistically significant 
change in binding affinities; however, there was 
a significant decrease in number of high affinity 
binding sites (1,413 & 153 vs. 246 -+ 73, P < 
0.05) during liver regeneration as determined by 
Scatchard analysis (Fig. 5, Table 111). 
To ascertain that there was significantly less 
binding of 1251-tyr11-SS-14 to hepatocytes ob- 
tained from regenerating liver than that from 
control livers, we covalently cross-linked the 
bound complex using homobifunctional cross- 
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Fig. 4. Displacement of '251-tyr1'-SS-l 4 binding to hepato- 
cytes obtained from control livers (closed circle) and 18 h 
regenerating livers (open circle). Hepatocytes and 1251-tyr - 
SS-14 (50 pmol/L) were incubated with the increasing concen- 
tration of synthetic SS-14. The data are representative of tour or 
more experiments. 
$ m 0 . 0 6 1  
D - 
N - 
ln - 0.02 d \ 
0.00 
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Fig. 5. Scatchard plot of '251-tyr11-SS-14 binding to hepato- 
cytes obtained from rats 18 h after control livers (closed circk) 
or 18 h regenerating livers (open circle). Hepatocytes were 
incubated with 1L51-tyr"-SS-l 4 and increasing concentrations 
of synthetic SS-14. Each point is a mean of duplicate determina- 
tions from an experiment and is a representative of four experi- 
ments. 
PAGE gels of the cross-linked 1251-tyr1 l-SS-14 
complexes showed a band of radioactivity of 
molecular weight 70,000 D in hepatocytes ob- 
tained from control, 6, and 24 h regenerating 
livers. In order to compare the intensity of the 
band, care was taken to incubate equal amounts 
of hepatocytes protein with same amount of 
radioactivity. A fainter band was obtained in 
hepatocytes obtained at 6 h than those obtained 
from sham operated livers (Fig. 6). There were 
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TABLE 111. Binding Affinities of 1251-tyr1*-SS-14 for its Binding Sites on Rat Hepatocytes Obtained 
After Sham Operation or 18 h After Hepatectomyi 
Affinity constant (Kd) 
nM (mean * SEM) No. of binding sites (mean * SEMI 
High Low High Low 
Sham 6.55 2 0.61 510 + 203 1,413 * 153* 8,309 * 2,392 
Regenerating liver 5.05 + 1.47 465 98 246 73* 6,458 + 2,492 
‘Values were obtained by Scatchard analysis and represent the mean & SEM f rom 4 separate experiments. 
*P < 0.05. 
-3 
Mrx  10 
42.6 - 
1 2 3 4  
Fig. 6. Affinity labeling of 1251-tyr”-SS-l 4 binding protein on 
hepatocytes obtained from sham operated (sham) and regener- 
ating livers. Lane 7, sham; lane 2, 6 h; lane 3, 18 h, and lane 4, 
24 h after partial hepatectomy. Hepatocytes were incubated 
with 1251-tyr11-SS-l 4 (200 pmol/L) separately and then washed 
with ice-cold binding buffer. The radiolabeled complex was 
cross linked with 100 kmo l /M DSS for 20 min at 4°C and then 
quenched (see Materials and Methods). Cross-linked complex 
was then subjected to SDS-PACE (7.5%). An autoradiography is 
representative of two experiments. 
no major differences observed in the intensity of 
the band obtained from control and 24 h regen- 
erating livers. 
DISCUSSION 
The present studies demonstrate that the anti- 
proliferative effect of SS-14 on insulin stimu- 
lated isolated rat hepatocytes proliferation was 
observed in hepatocytes obtained from control 
rats but was not observed in the hepatocytes 
obtained in regenerating livers between 2 and 
24 h after partial hepatectomy. Similarly, gluca- 
gon-stimulated tritiated thymidine incorpora- 
tion showed inhibition by SS-14 in hepatocytes 
obtained from control rats but there was no 
inhibition by SS-14 in hepatocytes obtained 18 h 
after partial hepatectomy. Our findings also in- 
dicate that the inhibitory effect of SS-14 is not 
caused by cytotoxicity, since albumin secretion 
in presence of SS-14 continued [Hashimoto et 
al., 19931 and the cells appear healthy and vi- 
able. The preferential inhibition of the antipro- 
liferative effect of SS-14 on hepatocytes ob- 
tained after partial hepatectomy supports the 
hypothesis that HTX removes the proliferative 
suppressive effects of SS-14 by a reduction in 
SS-14 receptor number in regenerating liver. 
The concentration of SS-14 needed to inhibit 
the DNA synthesis of insulin and glucagon in 
our control preparations was 10 nM, which is 
higher than the circulatory concentration [Ber- 
elowitz et al., 19781. Such differences may be 
explained by the short half-life of SS-14 and its 
rapid degradation in culture [Chou et al., 1987; 
Sacks et al., 1977,19841. Further, SS-14 is found 
in low concentrations in liver [Patel et al., 19811 
and high concentrations in pancreas and gastric 
mucosa, where it acts in a paracrine fashion 
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[Orci and Unger, 1975; Guillemin and Gerich, 
19761. It is possible that transitory increases in 
local cellular concentration of SS-14 may induce 
its paracrine action in control state. The absence 
of inhibitory action of SS-14 during liver regen- 
eration may be due to  number of causes. Limita- 
tion in availibility of number receptor sites of 
SS-14 may result in lack of inhibitory action by 
SS-14. 
Our data demonstrate that lZ5I-tyrl1-SS-14 
specifically binds to hepatocytes (Fig. 41, and 
when bound material is cross-linked with homo- 
bifunctional cross-linking reagent, solubilized, 
electrophoresed on polyacrylamide, and autora- 
diographed, a single labeled protein band of the 
molecular weight equal to  70,000 was observed 
(Fig. 6). This observation is agreement with our 
previous observation of a somatostatin specific 
binding protein of the molecular weight equals 
70,000 on rat liver plasma membranes [Raper et 
al., 19921. Further, we have identified high and 
low affinity binding sites in hepatocytes (Fig. 5, 
Table 111). This observation is supported by 
Yamada et al. [1992]. However, we could iden- 
tify only one site in liver plasma membranes 
[Raper et al., 19921. Variation could be ex- 
plained by the loss of binding sites in the liver 
plasma membranes by the harsher treatment 
during isolation of the plasma membranes. Be- 
sides, the data are similar to those in parietal 
cells and lymphocytes [Sreedharn et al., 1989; 
Parks et al., 19851. The high affinity binding 
sites were significantly lower in the regenerat- 
ing liver when compared to control rats. How- 
ever, the affinity constant remain unchanged in 
hepatocytes obtained from control and regener- 
ating livers. The decrease in the number of 
binding sites during liver regeneration can ex- 
plain the lack of SS-14 action in inhibiting triti- 
ated thymidine incorporation in regenerating 
liver (Fig. 1, Table I). The observation of a faint 
band at a molecular weight equal to 70,000 at 6 
h after hepatectomy (Fig. 6) further confirms 
our observation of less binding of SS-14 to its 
binding sites just after hepatectomy (Fig. 3). 
The data support a physiological role for the 
recently identified hepatic SS-14 receptor [Raper 
et al., 1992; Ziegeler et al., 19881 and its mRNA 
in the liver Wamada et al., 19921. Second messen- 
ger systems participate in the regulation of cellu- 
lar proliferation [Dumont et al., 19891. The ad- 
enylate cyclase system is a well known second 
messenger system that has been postulated to 
play a major role in the cell proliferation [Ha- 
segwa et al., 1980; Kokudo et al., 1991; Raper et 
al., 1991bI. In addition, the SS-14 receptor is 
shown to be coupled to the adenylyl cyclase 
system in several types of cells [Reisine arid 
Gould, 19891. Our studies show that there is a n  
increase in intracellular CAMP synthesis during 
liver regeneration (Table 11). This data support 
the observation of Whitfield et al. [19801 of' 
increased CAMP levels in regenerating liver tls- 
sues. Further, insulin stimulates intracellular 
CAMP accumulation in the isolated hepatocytes 
and is inhibited by SS-14 in control rats U'akk 
11). These data are in agreement with the obser- 
vation of Gettys et al. [1988] of increased accu- 
mulation (between 2 and 5 min) of preloaded 
hydrolyzable analogue of CAMP in the hepato- 
cytes. In regenerating liver, SS-14 inhibited in- 
sulin stimulated CAMP accumulation (Table I [)  
The data indicate that SS-14 binding sites arc! 
coupled to the adenylate cyclase system in regen- 
erating livers as well. 
Liver regeneration provides an in vivo and in 
vitro model to understand proliferative pro- 
cesses. Decreases in somatostatin binding sites 
in regenerating livers open up new avenues t c i  
study the mechanism of decreases in number 
and negative control. However, since somat osta- 
tin inhibits DNA synthesis in control hepato- 
cytes but has no effect on hepatocytes obtained 
from 2 to 24 h regenerating livers [Kokudo et 
al., 19921 (Figs. 1, 2, Table I) and the binding 
sites are regulated by guanine nucleotide pro- 
tein [Raper et al., 19921, it can be concluded that 
SS-14 binding to its receptors on the liver plays 
a physiological role in the liver regeneration. 
REFERENCES 
Berelowitz M, Kronheim S, Pimstone B, Shapiro B (1978): 
Somatostatin-like immunoreactivity in rat hlood-charac- 
terization, regional differences and response to  oral arid 
intravenous glucose. J Clin Invest 62:1410-1414. 
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rievei J, 
Guillemin R (1973): Hypothalamic polypeptide that inhib- 
its the secretion of immunoreactive pituitary growth hor- 
mone. Science 179:77-79. 
Chou CK, Ho LT, Ting LP, Hu C, Su TS, Chang WC. Sueri 
CS, Huang MY, Chang C (1987): Selective suppression of 
insulin-induced proliferation of cultured human hepa- 
toma cells by somatostatin. J Clin Invest 79:175-178. 
Conlon JM, Whittaker J, Hammond V, Alherti KGMM 
(1981): Metabolism of somatostatin and its analogues hy 
the liver. Biochim Biophys Acta 677234242, 
Dumont JE,  Jauniaux JC, Roger PP (1989): The cyclic 
AMP-mediated stimulation of cell proliferation. Trends 
Biochem Sci 14:67-71. 
Regulation of Liver Regeneration By SS-14 265 
Gettys TW, Blackmore PF, Corbin JD (1988): An assess- 
ment of phosphodiesterase activity in situ after treatment 
of hepatocytes with hormones. Am J Physiol 254:E449- 
E453. 
Guillemin R, Gerich J E  (1976): Somatostatin-physiological 
and clinical significance. Annu Rev Med 27:379-388. 
Harris AG (1990): Future medical prospects of sandostatin. 
Metabolism 39(Suppl2): 180-185. 
Hasegwa K, Namai K, Koga M (1980): Induction of DNA 
synthesis in adult rat hepatocytes cultured in a serum- 
free medium. Biochem Biophys Res Commun 95:243-248. 
Hashimoto M, Kothary PC, Raper SE (1993): Effects of 
TGFa and somatostatin on processing of liver regenera- 
tion in the rats. Regul Pept 44:49. 
Kokudo N, Kothary PC, Eckhauser FE, Raper SE (1991): 
Inhibitory effects of somatostatin on hepatocyte prolifera- 
tion are mediated by CAMP. J Surg Res 51:113-118. 
Kokudo N, Kothary PC, Eckhauser F, Nakamura T, Raper 
SE (1992): Inhibition of DNA synthesis by somatostatin 
in rat hepatocytes. Stimulated by hepatocyte growth fac- 
tor or epidermal growth factor. Am J Surg 163:169-173. 
Larsson LI, Goltermann N, DeMagostris L, Rehfeld JF, 
Schwartz TW (1979): Somatostatin cell processes as path- 
ways for paracrine secretion. Science 205: 1393-1397. 
Morriset J (1984): Somatostatin: A potential antigrowth 
factor for the exocrine pancreas. Regul Pept 1O:ll-22. 
Orci L, Unger RH (1975): Functional subdivision of islets of 
langerhans and possible role of D-cells. Lancet ii:1243- 
1244. 
Parks J, Chiba T, Yokotani K, Delvalle J ,  Yamada T (1985): 
Somatostatin receptors on canine fundic D-cells: Evidence 
for autocrine regulation of gastric somatostatin. Am J 
Patel YC, Wheatley T, Ning C (1981): Multiple forms of 
immunoreactive somatostatin: Comparison of distribu- 
tion in neural and non-neural tissues and portal plasma in 
the rat. Endocrinology 109:1943-1949. 
Raper SE, Kothary PC, Kokudo N, DelValle J (1991a): The 
liver plays an important role in the regulation of somato- 
statin-14 metabolism in the rat. Am J Surg 161:184-189. 
Raper SE, Kothary PC, Kokudo N (1991b): Somatostatin-14 
blocks the hepatotrophic effects of insulin in the rat. J 
Surg Res 50:386-390. 
Physol257:G235-G241. 
Raper SE, Kothary PC, DelValle J (1992): Identification and 
partial characterization of a somatostatin-14 binding pro- 
tein on rat liver plasma membrane. Hepatology 16:433- 
439. 
Reisine T, Gould S (1989): Pertussis toxin blocks somatosta- 
tin inhibition of calcium mobilization and reduces the 
affinity of somatostatin receptors for agonists. J Pharma- 
col Exp Ther 235:551-557. 
Ruggere MD, Patel YC (1985): Hepatic metabolism of so- 
matostatin-14 and somatostatin-28: Immunohistochemi- 
cal characterization of the metabolic fragments and com- 
parison of cleavage sites. Endocrinology 11 7:88-96. 
Sacks HS, Terry LC, Wright RK, Stenz FB (1984): Somato- 
statin metabolism: Difference in clearance of N-terminal 
and central portion of molecule during perfusion of rat 
liver. Am J Physiol 146:G226-234. 
Sacks HS, Waligora K, Matthews J ,  Pimstone BL (1977): 
Inhibition by somatostatin of glucagon-induced glucose 
release from the isolated perfused rat liver. Endocrinology 
101:1751-1759. 
Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ  (1989): 
Distinct subsets of somatostatin receptors on cultured 
human lymphocytes. J Biol Chem 264:949-952. 
Weinstein I, Wasfi I, Heimberg M (1981): Lack of effect of 
somatostatin on the glucagon-induced alteration of he- 
patic metabolism of ( l-14C)oleate. Biochim Biophys Acta 
664: 124-132. 
Whitfield JF,  Boynton AL, MacManus JP, Rixon RH, Sikor- 
ska M, Tsang B, Walker PR, Swierenga SHH (1980): The 
role of calcium and cyclic AMP in cell proliferation. Ann N 
Y Acad Sci 339:216-240. 
Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S 
(1992): Cloning and functional characterization of a fam- 
ily of human and mouse somatostatin receptors expresses 
in brain, gastrointestinal tract and kidney. Proc Natl Acad 
Sci U S A 89:251-255. 
Ziegler K, Frimmer M, Kessler H, Haupt A (1988): Azidoben- 
zamido-008, a new photosensitive substrate for the “mul- 
tispecific bile acid transporter” of hepatocytes: Evidenced 
for a common transport system for bile acids and cycloso- 
matostatins in basolateral membranes. Biochim Biophys 
Acta 945: 263-272. 
